Total plasma homocysteine and insulin levels in type 2 diabetic patients with secondary failure to oral agents [14]

Diabetes Care

Volumn 22, Issue 12, 1999, Pages 2097-2099

  Drzewoski, Józef ^c   Czupryniak, Leszek ^b   Chwatko, Grazyna ^a   Bald, Edward ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b N Barlicki University Hospital No 1 of Medical University of Lodz   (Poland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY RISK; DIABETIC ANGIOPATHY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT FAILURE;

EID: 0033361034     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.12.2097     Document Type: Letter

References (14)

1. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH: Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 39:1764-1779, 1993
2. The European Concerted Action Project: Plasma homocysteine as a risk factor for vascular disease. JAMA 277:1775-1781, 1997
3. Nehler MR, Taylor LM Jr, Porter JM: Homocysteinemia as a risk factor for atherosclerosis: a review. Cardiovasc Surg 5: 559-567, 1997
4. Stehouwer CDA, Weijenberg MP, van der Berg M, Jakobs C, Feskens EJM, Kromhout D: Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men: a 10-year follow-up. Arterioscler Thromb Vasc Biol 18:1895-1901, 1998
5. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP: Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM Diabetes Care 21:841-848, 1998
6. Lanfredini M, Fiorina P, Peca MG, Veronelli A, Mello A, Astorri E, Dall'Aglio P, Craveri A: Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus subjects. Metabolism 47:915-921, 1998
7. Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CDA: Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus; a population-based study Arterioscler Thromb Vasc Biol 18:133-138, 1998
8. Munshi MN, Stone A, Fink L, Fonseca V: Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism 45: 133-135, 1996
9. Passaro A, Solini A, D'Elia K, Pareschi PL, Carantoni M, Fellin R: Factors influencing plasma homocysteine as determinant of cardiovascular risk in type 2 diabetes mellitus. Diabetologia 41 (Suppl. 1):A337, 1998
10. Cronin CC, McPartlin JM, Barry DG, Ferriss JB, Scott JM, Weir DG: Plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 21:1843-1847, 1998
11. Robillon JF, Canivet B, Candito M, Sadoul JL, Jullien D, Morand P, Chambon P, Freychet P: Type 1 diabetes mellitus and homocyst(e)ine. Diabetes Metab 20:494-496, 1994
12. Hultberg B, Agardh CD, Agardh E, Lovestam-Adrian M: Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus: a five-year follow-up study. Scand J Clin Lab Invest 57:595-600, 1997
13. Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA, Henry RR: Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism 47: 686-689, 1998
14. Jacobs RL, House JD, Brosnan ME, Brosnan JT: Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 47:1967-1970, 1998